Health e News
- ///News
There is much to worry about regarding the multi-vitamin supplements being marketed to South Africa’s HIV-positive population by the German doctor, Matthias Rath, according to the Department of Health’s own nutrition expert, Lynne Moeng.
The worldwide shortage of health workers means that rich countries are not likely to stop poaching health workers from poorer countries.
- ///Health
Two HIV-positive women in Khayelitsha died within weeks of being convinced to discard their medication in favour of vitamins touted as a cure by the Dr Rath Health Foundation, while others say they were told to strip to their underwear, photographed and had blood taken without giving consent.
- ///News
Lack of funds is behind the decision, amid claims of “protocol violations” and counter-claims of unilateral decision-making by the funder.
Children tend to do better on antiretroviral treatment than adults, but many treatment sites are nervous to treat them.
- ///Health
A new school of thought in gender and AIDS education is emerging. It reckons that women should not be seen simply as passive victims in the transmission of HIV.
South Africa now has the biggest prevention of mother to child HIV transmission (PMTCT) programme in the world. Health-e speaks to the health department’s Dr Nomonde Xundu about its challenges and successes.
Fear of antiretroviral drugs meant that most patients at one of the country’s oldest HIV/AIDS treatment clinics waited until they were desperate before seeking treatment.
Only 5% of babies born to HIV positive mothers at a small, dedicated hospital get the virus.
- ///Health
Like many young South Africans his future was confined by financial constraints. But even so, after matriculating, young Raphakisa Botha could have chosen a number of other paths but instead he became a gender activist.
- ///Health
The message ‘it pays to know your HIV status’ hasn’t caught on very well with most South African men, according to a study published recently.
While generic production has brought down the prices of most first-line anti-retrovirals from over U$10 000 (R70 000) in 2000 to as little as U$150 (R1 050) per patient per year in June this year, prices of newer ARVs and formulations for children are up to 12 times higher.